Affinivax

Affinivax is a clinical stage biotech firm with an innovative, advanced approach to vaccine and immunotherapy development for infectious and other immune-related conditions. This unique and highly effective vaccination technology – known as Multiple Antigen Presenting System (MAPS) – facilitates the strong binding of protective polysaccharides and proteins in a single vaccine, leading to a diverse and protective B- and T-cell immune response.